Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
Taiwan plans to set up drone testing facility in Chiayi
12/21/2024 06:25 PM - Cross-Strait
Experts sound alarm over low awareness of China threat among Taiwan's youth
12/21/2024 06:08 PM - Society
5 released on bail over deadly fire at Taichung PX Mart facility
12/21/2024 05:45 PM - Politics
Taiwan's Cabinet to take countermeasures after contentious amendments passed
12/21/2024 04:18 PM - Business
Economics minister pushes for industrial cooperation with Germany, Czechia
12/21/2024 04:10 PM